Genovate Biotechnology Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	169.04	221.6	180.03	194.17	198.44
Short-Term Investments	265.16	259.67	324.03	282.88	177.98
Trading Asset Securities	47.76	40.2	35.25	20	13
Cash & Short-Term Investments	481.96	521.47	539.3	497.05	389.42
Cash Growth	-7.58%	-3.31%	8.50%	27.64%	-7.54%
Accounts Receivable	86.24	89.06	87.87	96.13	94.39
Other Receivables	1.32	1.4	1.28	27.77	0.77
Receivables	87.57	90.46	89.15	123.89	95.16
Inventory	143.83	145.87	139.64	145.86	139.94
Prepaid Expenses	5.94	7.34	3.39	14.79	10.38
Other Current Assets	0.01	0.31	0.29	0.28	0.02
Total Current Assets	719.3	765.45	771.77	781.88	634.93
Property, Plant & Equipment	410.42	393.95	392.12	403.29	409.6
Long-Term Investments	339.53	398.55	397.28	351.6	439.52
Other Intangible Assets	6.19	3.11	4.66	0.8	1.49
Other Long-Term Assets	30.93	29.16	34.62	26.87	29.97
Total Assets	1,506	1,590	1,600	1,564	1,516
Accounts Payable	29.97	40.28	32.87	45.91	35
Accrued Expenses	35.06	37.49	29.57	35.55	29.4
Current Portion of Leases	1.23	0.86	0.67	1.25	0.74
Current Income Taxes Payable	0.18	4.39	1.37	3.27	3.4
Current Unearned Revenue	1.79	1.96	4.9	4.73	4.03
Other Current Liabilities	57.1	51.5	48.36	41.12	38.05
Total Current Liabilities	125.32	136.48	117.73	131.84	110.61
Long-Term Leases	0.61	1.73	0.02	0.59	0.09
Pension & Post-Retirement Benefits	-	2.75	13.7	21.06	25.82
Other Long-Term Liabilities	0.12	0.12	0.24	0.12	0.12
Total Liabilities	126.05	141.08	131.69	153.6	136.65
Common Stock	1,149	1,127	1,094	1,094	1,100
Additional Paid-In Capital	210.71	210.66	210.56	210.51	208.93
Retained Earnings	131.77	152.63	177.79	202.18	167.97
Treasury Stock	-25.72	-25.72	-	-	-63.03
Comprehensive Income & Other	-85.32	-15.01	-13.34	-95.62	-35.04
Shareholders' Equity	1,380	1,449	1,469	1,411	1,379
Total Liabilities & Equity	1,506	1,590	1,600	1,564	1,516
Total Debt	1.84	2.58	0.68	1.84	0.83
Net Cash (Debt)	480.12	518.88	538.62	495.21	388.59
Net Cash Growth	-7.47%	-3.66%	8.77%	27.44%	-7.29%
Net Cash Per Share	4.22	4.52	4.68	4.37	3.43
Filing Date Shares Outstanding	113.75	113.75	114.91	114.91	113.33
Total Common Shares Outstanding	113.75	113.75	114.91	114.91	113.33
Working Capital	593.98	628.97	654.05	650.04	524.32
Book Value Per Share	12.13	12.74	12.78	12.28	12.17
Tangible Book Value	1,374	1,446	1,464	1,410	1,377
Tangible Book Value Per Share	12.08	12.71	12.74	12.27	12.15
Land	140.74	140.74	140.74	140.74	140.74
Buildings	284.41	285.06	282.26	281.85	283.17
Machinery	136.25	168.27	158.6	180.44	160.91
Construction In Progress	36.53	2.49	1.88	0.61	0.41

Source: S&P Global Market Intelligence. Standard template. Financial Sources.